• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1993 - 2000年阿尔伯塔省引入全系统姑息治疗的使用情况及成本

Utilization and costs of the introduction of system-wide palliative care in Alberta, 1993-2000.

作者信息

Fassbender Konrad, Fainsinger Robin, Brenneis Carleen, Brown Pam, Braun Ted, Jacobs Philip

机构信息

Alberta Cancer Board Palliative Care Research Initiative, Edmonton.

出版信息

Palliat Med. 2005 Oct;19(7):513-20. doi: 10.1191/0269216305pm1071oa.

DOI:10.1191/0269216305pm1071oa
PMID:16295282
Abstract

BACKGROUND

De-institutionalization of health care services provided to terminally ill cancer patients is a cost-effective strategy that underpins health care reforms in Canada. The objective of this study therefore is to evaluate the economic implications associated with Canadian innovations in the delivery of palliative care services.

METHODS

We identified 16,282 adults who died of cancer between 1993 and 2000 in two Canadian cities with newly introduced palliative care programs. Linkage of administrative databases was used to measure healthcare resource utilization. We sought to describe the utilization of palliative care services and its consequences for overall health care system costs.

RESULTS

Use of palliative services increased from 45 to 81% of cancer patients during the study period. Identifiable public health care services cost dollars 28093Cdn/patient (19033US dollars, 11,508GBł, 17,778 euro) for terminally ill cancer patients in their last year of life. Acute care accounted for two-thirds (67%) of these costs; physician (10%), residential hospice care (8%), nursing homes (6%), home care (6%) and prescription medications (3%) comprise the remainder. Increased costs associated with the introduction of palliative care programs were offset by cost savings realized when terminally ill cancer patients spent less time in hospital. Palliative home care and residential hospice care accounted for the bulk of this substitution effect. Cost neutrality was observed from the public perspective.

DISCUSSION

These results demonstrate that the introduction of comprehensive and community-based palliative care services resulted in increased palliative care service delivery and cost neutrality, primarily achieved through a decreased use of acute care beds.

摘要

背景

为晚期癌症患者提供的医疗服务去机构化是一种具有成本效益的策略,是加拿大医疗改革的基础。因此,本研究的目的是评估加拿大姑息治疗服务提供创新所带来的经济影响。

方法

我们在加拿大两个新引入姑息治疗项目的城市中,确定了1993年至2000年间死于癌症的16282名成年人。利用行政数据库的关联来衡量医疗资源的利用情况。我们试图描述姑息治疗服务的利用情况及其对整体医疗系统成本的影响。

结果

在研究期间,姑息治疗服务的使用从癌症患者的45%增加到81%。对于晚期癌症患者,可识别的公共医疗服务在其生命的最后一年每位患者花费28093加元(19033美元、11508英镑、17778欧元)。急性护理占这些成本的三分之二(67%);其余部分包括医生(10%)、住院临终关怀护理(8%)、养老院(6%)、家庭护理(6%)和处方药(3%)。引入姑息治疗项目带来的成本增加被晚期癌症患者住院时间缩短所实现的成本节约所抵消。姑息家庭护理和住院临终关怀护理占了这种替代效应的大部分。从公共角度观察到成本中性。

讨论

这些结果表明,引入全面的社区姑息治疗服务导致姑息治疗服务的提供增加和成本中性,主要是通过减少急性护理床位的使用来实现的。

相似文献

1
Utilization and costs of the introduction of system-wide palliative care in Alberta, 1993-2000.1993 - 2000年阿尔伯塔省引入全系统姑息治疗的使用情况及成本
Palliat Med. 2005 Oct;19(7):513-20. doi: 10.1191/0269216305pm1071oa.
2
Societal costs of home and hospital end-of-life care for palliative care patients in Ontario, Canada.加拿大安大略省姑息治疗患者居家和医院临终关怀的社会成本。
Health Soc Care Community. 2015 Nov;23(6):605-18. doi: 10.1111/hsc.12170. Epub 2014 Dec 2.
3
The Costs of Waiting: Implications of the Timing of Palliative Care Consultation among a Cohort of Decedents at a Comprehensive Cancer Center.等待的代价:综合癌症中心一批死者中姑息治疗咨询时机的影响
J Palliat Med. 2016 Jan;19(1):69-75. doi: 10.1089/jpm.2015.0119. Epub 2015 Nov 30.
4
Resource use and costs of end-of-Life/palliative care: Ontario adult cancer patients dying during 2002 and 2003.临终关怀/姑息治疗的资源使用与成本:2002年和2003年期间安大略省成年癌症临终患者
J Palliat Care. 2011 Summer;27(2):79-88.
5
Impact of aggressive management and palliative care on cancer costs in the final month of life.积极治疗与姑息治疗对临终前最后一个月癌症治疗费用的影响。
Cancer. 2015 Sep 15;121(18):3307-15. doi: 10.1002/cncr.29485. Epub 2015 May 29.
6
Taking care of terminally-ill patients at home - the economic perspective revisited.在家照料绝症患者——对经济视角的重新审视
Palliat Med. 2007 Sep;21(6):537-41. doi: 10.1177/0269216307080822.
7
Resource utilization and cost analyses of home-based palliative care service provision: the Niagara West End-of-Life Shared-Care Project.基于家庭的姑息治疗服务提供的资源利用和成本分析:尼亚加拉西部临终关怀共享项目。
Palliat Med. 2013 Feb;27(2):115-22. doi: 10.1177/0269216311433475. Epub 2012 Jan 16.
8
Cost analysis of palliative care for terminally ill cancer patients in the UK after switching from weak to strong opioids. Palliative Care Advisory Committee.英国晚期癌症患者从弱阿片类药物转换为强阿片类药物后的姑息治疗成本分析。姑息治疗咨询委员会。
Pharmacoeconomics. 1998 Sep;14(3):285-97. doi: 10.2165/00019053-199814030-00005.
9
A randomized controlled trial of the cost-effectiveness of a district co-ordinating service for terminally ill cancer patients.一项针对晚期癌症患者地区协调服务成本效益的随机对照试验。
Palliat Med. 1996 Apr;10(2):151-61. doi: 10.1177/026921639601000210.
10
Association of healthcare expenditures with aggressive versus palliative care for cancer patients at the end of life: a cross-sectional study using claims data in Japan.终末期癌症患者接受积极治疗与姑息治疗的医疗支出关联:一项使用日本理赔数据的横断面研究。
Int J Qual Health Care. 2014 Feb;26(1):79-86. doi: 10.1093/intqhc/mzt081. Epub 2013 Nov 13.

引用本文的文献

1
Impact of outpatient palliative care on healthcare costs in Germany - an analysis of cancer and non-cancer patients based on health insurance data.德国门诊姑息治疗对医疗费用的影响——基于健康保险数据对癌症和非癌症患者的分析
Health Econ Rev. 2025 Aug 20;15(1):70. doi: 10.1186/s13561-025-00604-z.
2
The Economic Cost of Nursing Care of Palliative Patients in the Emergency Department.急诊科姑息治疗患者护理的经济成本
Healthcare (Basel). 2025 Feb 15;13(4):421. doi: 10.3390/healthcare13040421.
3
The Construction of British Columbia's Palliative Care Benefits Policy and Implications for Nursing Practice.
不列颠哥伦比亚省姑息治疗福利政策的构建及其对护理实践的影响。
Policy Polit Nurs Pract. 2025 Feb;26(1):74-84. doi: 10.1177/15271544241298656. Epub 2024 Dec 9.
4
Costs of Palliative Care in Oncological and Non-Oncological Patients with Different Types of Ambulatory-Based Attention: Cost-Study Protocol.不同类型门诊护理的肿瘤和非肿瘤患者姑息治疗成本:成本研究方案
Diseases. 2024 Oct 5;12(10):243. doi: 10.3390/diseases12100243.
5
Palliative Care Costs in Different Ambulatory-Based Settings: A Systematic Review.不同门诊环境下的姑息治疗成本:系统评价。
Pharmacoeconomics. 2024 Mar;42(3):301-318. doi: 10.1007/s40273-023-01336-w. Epub 2023 Dec 27.
6
Value of embedded palliative care: outpatient palliative care and health care utilization for patients with hematologic malignancies.嵌入式姑息治疗的价值:血液系统恶性肿瘤患者的门诊姑息治疗与医疗保健利用情况
Blood Adv. 2023 Jul 11;7(13):3146-3149. doi: 10.1182/bloodadvances.2022009039.
7
Oncologist conceptualizations of pediatric palliative care: challenges and definitions.肿瘤学家对儿科姑息治疗的概念化理解:挑战与定义。
Support Care Cancer. 2021 Jul;29(7):3981-3989. doi: 10.1007/s00520-020-05959-z. Epub 2021 Jan 3.
8
Frequency, Timing, and Predictors of Palliative Care Consultation in Patients with Advanced Cancer at a Tertiary Cancer Center: Secondary Analysis of Routinely Collected Health Data.晚期癌症患者在一家三级癌症中心接受姑息治疗咨询的频率、时间和预测因素:基于常规收集健康数据的二次分析。
Oncologist. 2020 Aug;25(8):722-728. doi: 10.1634/theoncologist.2019-0384. Epub 2020 Jun 9.
9
Optimal care at the end of life (OPAL): study protocol of a prospective interventional mixed-methods study with pretest-posttest-design in a primary health care setting considering the view of general practitioners, relatives of deceased patients and health care stakeholders.终末期最佳护理(OPAL):一项在初级医疗保健环境中进行的前瞻性干预性混合方法研究的研究方案,考虑到全科医生、已故患者亲属和医疗保健利益相关者的观点,采用预测试后设计。
BMC Health Serv Res. 2019 Jul 15;19(1):486. doi: 10.1186/s12913-019-4321-9.
10
Factors related to and economic implications of inhospital death in German lung cancer patients - results of a Nationwide health insurance claims data based study.德国肺癌患者住院死亡的相关因素及经济影响——一项基于全国医疗保险理赔数据的研究结果
BMC Health Serv Res. 2018 Oct 19;18(1):793. doi: 10.1186/s12913-018-3599-3.